Remote Patient Monitoring (RPM) has rapidly moved from a fringe tool to a foundational component of modern healthcare, particularly in managing chronic and high-risk conditions like diabetes. The clinical case for RPM is strong, but many physicians assume that reimbursement is stuck in the past - and might be surprised to see how fast the reimbursement landscape has caught up.
Medicare and private insurers cover RPM nationally for high-risk pregnancies. Additionally, 80% of state Medicaid plans also reimburse directly for RPM. This shift in care delivery is further being codified by lawmakers at both the state level and the federal government, who are actively developing new laws and policies that support its growth.
For OB-GYNs, MFMs, and digital health leaders focused on gestational diabetes management, staying informed about reimbursement policy is key to designing care models that are both effective and financially sustainable.
The Current State of RPM Reimbursement
At the federal level, RPM is reimbursable under Medicare using CPT codes 99453, 99454, 99457, and 99458. These codes cover everything from device setup and data transmission to clinical time spent reviewing patient-generated health data. For patients with gestational diabetes, this might include continuous glucose monitoring (CGM) or periodic updates via a digital health app.
Medicaid coverage does vary significantly by state, but according to the Center for Connected Health Policy (CCHP), at least 39 states currently offer some form of reimbursement for RPM.
States Leading the Way
Even beyond reimbursement coverage, it’s clear that some states are not content to make small adjustments to billing and are pushing hard for more investment in RPM use in pregnancy.
In Arkansas, Governor Sanders recently signed the Healthy Moms, Healthy Babies Act, a sweeping maternal health initiative that includes mandated Medicaid reimbursement for RPM. Starting July 1, 2025, Arkansas Medicaid will cover remote monitoring for blood pressure, glucose, and even ultrasounds, which makes it one of the most progressive maternal telehealth reimbursement policies in the nation.
Georgia has emerged as a leader in using technology to improve maternal health outcomes, particularly for conditions like gestational diabetes. Several health systems and Medicaid plans are piloting wearable RPM solutions to monitor blood pressure, blood glucose, and other vital signs in pregnant patients. As highlighted by WABE, these tools are already demonstrating results by helping providers intervene earlier and prevent complications, especially in underserved and rural areas.
Building on this innovation, Georgia lawmakers recently passed the Georgia Momnibus Act, a comprehensive maternal health bill aimed at reducing the state’s high rates of maternal morbidity and mortality. The legislation, signed into law in 2024, expands Medicaid coverage for postpartum care, funds telehealth infrastructure, and supports the integration of remote monitoring tools into maternal health programs.
Together, the state’s policy momentum and proven success with wearable tech signal a growing readiness to make remote monitoring a standard part of maternal care—including for gestational diabetes management.
There are early signs that other states are getting on board as well — Alabama’s health department is investing in RPM for a variety of services (GDM included), and Tennessee has a bill working its way through the legislature that kickstarts a pilot program dedicated to remote patient monitoring for maternal hypertension and gestational diabetes.
What’s Happening at the Federal Level
Several bills currently before Congress could continue the significant expansion of RPM reimbursement nationwide, particularly for maternal care.
One of the most relevant is the Connected MOM Act (S.712), introduced by Senators Bill Cassidy and Maggie Hassan. This bipartisan bill would require CMS to evaluate state Medicaid coverage of RPM, especially for pregnant and postpartum individuals, and issue formal recommendations for national standards. The American Medical Association (AMA) has publicly endorsed the legislation, citing its potential to improve maternal and infant health outcomes through expanded access to technology.
Another important bill, introduced in May 2025 by Senators Marsha Blackburn and Mark Warner, is the Rural Patient Monitoring Access Act. This bill aims to standardize Medicare RPM reimbursement in rural areas, where broadband and specialty care access are often limited. Although not specific to maternal health, it would directly benefit OB-GYN and MFM practices managing high-risk pregnancies in rural communities.
Why It Matters for Gestational Diabetes
Gestational diabetes is one of the most common pregnancy complications, yet most care models still rely on periodic in-person visits and outdated paper logs. RPM offers a more proactive and continuous model of care, allowing providers to track blood glucose in real time, intervene earlier, and support patients with timely guidance.
The good news: much of this care is already reimbursable under Medicare and increasingly under Medicaid in leading states. The challenge is aligning clinical workflows and billing practices to capture that value, as well as staying ahead of policy shifts that are likely to expand coverage further.
As the legislative momentum builds at both the state and federal level, OB-GYN practices have an opportunity to modernize gestational diabetes care in a way that benefits patients and ensures financial sustainability.
Interested in building or scaling your RPM program for gestational diabetes?
LilyLink helps OB-GYN and MFM practices deliver tech-enabled care that fits seamlessly into existing workflows—and gets reimbursed.
Reach out to learn more, or download our guide on modernizing GDM care.
Resources:
https://www.fiercehealthcare.com/regulatory/rpm-access-act-introduced-congress
https://www.cchpca.org/topic/remote-patient-monitoring/
https://www.billtrack50.com/billdetail/1822171
https://www.arkansashouse.org/news/post/29458/2025-maternal-health-legislation
https://www.ama-assn.org/system/files/2024-nac-action-kit-connected-mom-act.pdf